Latest Insider Transactions at Nu Skin Enterprises, Inc. (NUS)
This section provides a real-time view of insider transactions for Nu Skin Enterprises, Inc. (NUS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NU SKIN ENTERPRISES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NU SKIN ENTERPRISES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 11
2021
|
D Matthew Dorny General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,200
+10.07%
|
$186,000
$30.63 P/Share
|
May 06
2021
|
Mark H Lawrence Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
500
-1.03%
|
$27,500
$55.0 P/Share
|
Apr 27
2021
|
Mark H Lawrence Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
800
-1.63%
|
$44,000
$55.02 P/Share
|
Apr 21
2021
|
Connie Mang Yee Tang Chief Global Growth Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,396
+50.0%
|
-
|
Apr 21
2021
|
Mark H Lawrence Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,148
-4.19%
|
$118,140
$55.02 P/Share
|
Apr 01
2021
|
D Matthew Dorny General Counsel |
SELL
Open market or private sale
|
Direct |
6,200
-11.2%
|
$328,600
$53.16 P/Share
|
Apr 01
2021
|
D Matthew Dorny General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,200
+10.07%
|
$186,000
$30.63 P/Share
|
Mar 15
2021
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-3.76%
|
$520,000
$52.65 P/Share
|
Mar 15
2021
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+9.82%
|
$300,000
$30.63 P/Share
|
Mar 10
2021
|
Edwina D Woodbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.1%
|
$561
$51.24 P/Share
|
Mar 09
2021
|
Joseph Y Chang Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
626
-3.37%
|
$31,926
$51.55 P/Share
|
Mar 04
2021
|
Ryan S Napierski President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,154
-1.39%
|
$56,546
$49.68 P/Share
|
Mar 04
2021
|
Joseph Y Chang Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
499
-2.62%
|
$24,451
$49.68 P/Share
|
Mar 04
2021
|
D Matthew Dorny General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
331
-0.67%
|
$16,219
$49.68 P/Share
|
Mar 04
2021
|
Ritch N Wood Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,795
-1.3%
|
$136,955
$49.68 P/Share
|
Mar 02
2021
|
Mark H Lawrence Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
910
-1.74%
|
$46,410
$51.66 P/Share
|
Mar 01
2021
|
D Matthew Dorny General Counsel |
SELL
Open market or private sale
|
Direct |
12,400
-10.58%
|
$644,800
$52.12 P/Share
|
Mar 01
2021
|
D Matthew Dorny General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
12,400
+16.69%
|
$372,000
$30.63 P/Share
|
Feb 18
2021
|
Daniel W Campbell Director |
BUY
Open market or private purchase
|
Indirect |
5,055
+33.55%
|
$247,695
$49.48 P/Share
|
Feb 18
2021
|
Daniel W Campbell Director |
BUY
Open market or private purchase
|
Direct |
5,055
+5.56%
|
$247,695
$49.49 P/Share
|
Feb 18
2021
|
Joseph Y Chang Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,125
-5.57%
|
$55,125
$49.77 P/Share
|
Feb 17
2021
|
Steven Lund Exec. Chairman of the Board |
BUY
Open market or private purchase
|
Indirect |
20,850
+7.97%
|
$1,000,800
$48.05 P/Share
|
Feb 17
2021
|
Daniel W Campbell Director |
BUY
Open market or private purchase
|
Indirect |
4,955
+50.0%
|
$247,750
$50.69 P/Share
|
Feb 17
2021
|
Daniel W Campbell Director |
BUY
Open market or private purchase
|
Direct |
4,955
+5.78%
|
$247,750
$50.6 P/Share
|
Feb 16
2021
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
7,000
-2.64%
|
$343,000
$49.56 P/Share
|
Feb 16
2021
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+7.22%
|
$210,000
$30.63 P/Share
|
Feb 15
2021
|
Joseph Y Chang Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,179
-5.52%
|
$56,592
$48.81 P/Share
|
Feb 15
2021
|
Joseph Y Chang Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,557
+23.48%
|
-
|
Feb 15
2021
|
Mark H Lawrence Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,339
-9.28%
|
$256,272
$48.81 P/Share
|
Feb 15
2021
|
Mark H Lawrence Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,015
+13.55%
|
-
|
Feb 15
2021
|
James D Thomas Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
710
-7.42%
|
$34,080
$48.81 P/Share
|
Feb 15
2021
|
James D Thomas Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,459
+20.44%
|
-
|
Feb 15
2021
|
D Matthew Dorny General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,161
-2.29%
|
$55,728
$48.81 P/Share
|
Feb 15
2021
|
D Matthew Dorny General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,278
+11.03%
|
-
|
Feb 15
2021
|
Ritch N Wood Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,546
-3.83%
|
$410,208
$48.81 P/Share
|
Feb 15
2021
|
Ritch N Wood Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,910
+9.68%
|
-
|
Feb 15
2021
|
Ryan S Napierski President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,720
-4.29%
|
$178,560
$48.81 P/Share
|
Feb 15
2021
|
Ryan S Napierski President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,235
+13.24%
|
-
|
Jan 20
2021
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
10,156
-12.14%
|
$599,204
$59.12 P/Share
|
Jan 20
2021
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,400
+9.12%
|
$252,000
$30.63 P/Share
|
Jan 15
2021
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
7,000
-8.51%
|
$385,000
$55.45 P/Share
|
Jan 15
2021
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+7.84%
|
$210,000
$30.63 P/Share
|
Jan 07
2021
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
4,844
-6.05%
|
$285,796
$59.05 P/Share
|
Jan 07
2021
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,600
+1.96%
|
$48,000
$30.63 P/Share
|
Jan 04
2021
|
D Matthew Dorny General Counsel |
SELL
Open market or private sale
|
Direct |
6,200
-6.23%
|
$341,000
$55.22 P/Share
|
Jan 04
2021
|
D Matthew Dorny General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,200
+10.92%
|
$186,000
$30.63 P/Share
|
Dec 15
2020
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
7,000
-8.19%
|
$350,000
$50.97 P/Share
|
Dec 15
2020
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+7.57%
|
$210,000
$30.63 P/Share
|
Dec 09
2020
|
Edwina D Woodbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.07%
|
$510
$51.74 P/Share
|
Dec 07
2020
|
Ryan S Napierski President and CEO |
SELL
Bona fide gift
|
Direct |
3,000
-3.68%
|
-
|